| Effect of Tacrolimus Versus Cyclosporine on Glucose Metabolism of Pancreas and Kidney Recipients in the Late (> 8 years) Posttransplant Period. | |
| | |
MedLine Citation:
|
PMID: 22099774 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Diabetogenic effects of immunosuppressive agents are of great importance in pancreas or islet transplantation. The aim of our study was to compare the glucose metabolism in type 1 diabetic kidney and pancreas recipients on tacrolimus (Tacro) versus cyclosporine-based (Cyclo) immunosuppression in the late posttransplant period. We examined 26 insulin-independent patients with stabile good renal function. They were at least 7 years after simultaneous pancreas and kidney transplantation and with unchanged immunosuppressive therapy for at least 6 years. The mean follow-up in Tacro (n = 13) and Cyclo (n = 13) groups were 9.7 ± 1.9 and 10.9 ± 1.3 years, respectively (P = .08). Fasting glycemia, insulin levels, glycosylated hemoglobin (HbA(1c)), a standard intravenous glucose tolerance test (IVGTT) with coefficient of glucose assimilation (K(G)) calculation and trough Tacro/Cyclo levels were assessed. Insulin sensitivity and insulin secretion were evaluated using the homeostasis model assessment (HOMA-IR, HOMA-B). Total C-peptide and insulin secretions were calculated as areas under the curves (AUC) from the serum levels during the IVGTT. Tacro and Cyclo groups did not differ in age and body mass index. We did not find any significant difference in any examined parameters of glucose metabolism (fasting glycemia, insulin and C-peptide levels, HbA(1c,) IVGTT with K(G), HOMA-IR, HOMA-B, AUC of C-peptide and AUC of insulin; P > .05). Two patients in the Tacro group and none in the Cyclo group had K(G) <0.8%/min. Seven recipients in the Tacro group and eight in the Cyclo group had the normal glucose tolerance with K(G) ≥ 1.2%/min. Trough Tacro or Cyclo levels did not correlate with any of examined parameters. The use of different types of calcineurin inhibitors in type 1 diabetic pancreas and kidney recipients had no effect on glucose metabolism in the late posttransplant period. |
| | |
Authors:
|
T Havrdova; T Jedinakova; K Lipar; J Skibova; F Saudek |
Related Documents
:
|
14767364 - Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic c... 18990924 - Loss of confidence in diabetes management. 19884294 - Managing diabetes in hemodialysis patients: observations and recommendations. 4068864 - Untoward sequelae of prolonged intubation. 7029444 - Primary hyperinsulinemia reduces surface active material flux in tracheal fluid of feta... 6449704 - Evolutionary origins of vertebrate hormones: substances similar to mammalian insulins a... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Transplantation proceedings Volume: 43 ISSN: 1873-2623 ISO Abbreviation: Transplant. Proc. Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0243532 Medline TA: Transplant Proc Country: United States |
Other Details:
|
Languages: eng Pagination: 3270-2 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 Elsevier Inc. All rights reserved. |
Affiliation:
|
Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ten years of simultaneous pancreas-kidney transplantation: a retrospective single-center analysis of...
Next Document: Evaluation of Segmental Pancreatic Function Using 11C-Methionine Positron Emission Tomography for Sa...